Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-10-17 11:04:32 UTC |
---|
Update Date | 2022-03-07 02:49:25 UTC |
---|
HMDB ID | HMDB0005036 |
---|
Secondary Accession Numbers | - HMDB0014726
- HMDB05036
- HMDB14726
|
---|
Metabolite Identification |
---|
Common Name | Fluticasone propionate |
---|
Description | Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone propionate binds to the glucocorticoid receptor. Unbound corticosteroids cross the membranes of cells such as mast cells and eosinophils, binding with high affinity to glucocorticoid receptors (GR). The results include alteration of transcription and protein synthesis, a decreased release of leukocytic acid hydrolases, reduction in fibroblast proliferation, prevention of macrophage accumulation at inflamed sites, reduction of collagen deposition, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability and subsequent edema, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. In the management of asthma, the glucocorticoid receptor complexes down-regulates proinflammatory mediators such as interleukin-(IL)-1, 3, and 5, and up-regulates anti-inflammatory mediators such as IκB (inhibits NF-κB). Corticosteroids are the most effective anti-inflammatory therapy for allergic diseases. They are believed to inhibit T helper cell type 2 (TH2 T-cell) activation through increased immunoregulatory T cell (CD4+CD25+) suppression (PMID: 15316506 ). Fluticasone propionate is marketed under the brand name Flixotide and Flixonase by Allen & Hanburys, and Flovent and Flonase by GlaxoSmithKline. Fluticasone propionate is only found in individuals that have used or taken this drug. |
---|
Structure | [H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Cutivate | ChEBI | Flonase | Kegg | Flovent | Kegg | Cutivic acid | Generator | Fluticasone propionic acid | Generator | Flovent diskus 250 | HMDB | Flovent diskus 50 | HMDB | CCI-18781cutivATE | HMDB | Flovent diskus 100 | HMDB | Flovent hfa | HMDB | FLUTICASONE | HMDB | CCI 18781 | HMDB | CCI-18781cutivic acid | HMDB | Asmatil | HMDB | Axotide | HMDB | Brethal | HMDB | Cultivate | HMDB | Flixonase | HMDB | Flixonase nasal spray | HMDB | Flixotide | HMDB | Flixotide disk | HMDB | Flixotide disks | HMDB | Flixotide inhaler | HMDB | Flovent diskus | HMDB | Flovent rotadisk | HMDB | Fluinol | HMDB | Flunase | HMDB | Flusonal | HMDB | Fluspiral | HMDB | Fluticasonpropionat allen | HMDB | Flutide | HMDB | Flutivate | HMDB | HFA, flovent | HMDB | Propionate, fluticasone | HMDB |
| Show more...
---|
Chemical Formula | C25H31F3O5S |
---|
Average Molecular Weight | 500.571 |
---|
Monoisotopic Molecular Weight | 500.184429407 |
---|
IUPAC Name | (1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14-{[(fluoromethyl)sulfanyl]carbonyl}-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl propanoate |
---|
Traditional Name | (1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14-{[(fluoromethyl)sulfanyl]carbonyl}-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl propanoate |
---|
CAS Registry Number | 80474-14-2 |
---|
SMILES | [H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C |
---|
InChI Identifier | InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1 |
---|
InChI Key | WMWTYOKRWGGJOA-CENSZEJFSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Steroid esters |
---|
Direct Parent | Steroid esters |
---|
Alternative Parents | |
---|
Substituents | - Steroid ester
- Androgen-skeleton
- Androstane-skeleton
- 3-oxosteroid
- Hydroxysteroid
- 6-halo-steroid
- 9-halo-steroid
- Oxosteroid
- 3-oxo-delta-1,4-steroid
- 11-beta-hydroxysteroid
- 11-hydroxysteroid
- Halo-steroid
- Delta-1,4-steroid
- Cyclic alcohol
- Halohydrin
- Secondary alcohol
- Ketone
- Carboxylic acid ester
- Thiocarboxylic acid ester
- Fluorohydrin
- Cyclic ketone
- Carbothioic s-ester
- Sulfenyl compound
- Carboxylic acid derivative
- Thiocarboxylic acid or derivatives
- Monocarboxylic acid or derivatives
- Organosulfur compound
- Alcohol
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Hydrocarbon derivative
- Alkyl halide
- Alkyl fluoride
- Organooxygen compound
- Organofluoride
- Organohalogen compound
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized | Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Fluticasone propionate GC-MS (Non-derivatized) - 70eV, Positive | splash10-005i-8973700000-7ae41b4f0c6c91175556 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Fluticasone propionate GC-MS (1 TMS) - 70eV, Positive | splash10-1003-4319060000-b20ab3b8b6ed86e8912c | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate , positive-QTOF | splash10-03dl-0497100000-b64248896abdef386eaf | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 50V, Positive-QTOF | splash10-0200-0790000000-4d8a865f47a79975f30a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 40V, Positive-QTOF | splash10-004i-0490000000-00982c202544f0c432e3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 50V, Positive-QTOF | splash10-0200-0790000000-9312e39ae770e7245a53 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 30V, Positive-QTOF | splash10-004l-0392000000-35466d5bb70b1d6f1634 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 20V, Positive-QTOF | splash10-01ox-0197000000-044d3734659c98c68da2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 10V, Positive-QTOF | splash10-0udi-0025290000-848a15088230876c1818 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 30V, Positive-QTOF | splash10-004l-0392000000-01368c6428b545907e1c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Fluticasone propionate 40V, Positive-QTOF | splash10-004i-0490000000-0fd22d1ac4b72bdebc1f | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 10V, Positive-QTOF | splash10-0zgi-4001930000-a7b82244d5b24f9d8272 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 20V, Positive-QTOF | splash10-0a6u-7092200000-aed6b52e614a380e2097 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 40V, Positive-QTOF | splash10-0cdi-8096100000-9e0fc4111fc6116e0ea3 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 10V, Negative-QTOF | splash10-01ox-9000100000-17674b637937da23d27e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 20V, Negative-QTOF | splash10-03kc-9000200000-0c5158a7b78371629485 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 40V, Negative-QTOF | splash10-08i0-9003100000-9fa5be631de6c09946db | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 10V, Positive-QTOF | splash10-0uei-0009860000-3f8f57d106338053ebf9 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 20V, Positive-QTOF | splash10-08i9-1009800000-aee94ac4fa03a5892a8b | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 40V, Positive-QTOF | splash10-01pc-9447100000-e80928204b8b61c38056 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 10V, Negative-QTOF | splash10-00di-9000400000-1b0cb5667fe2a113acc9 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 20V, Negative-QTOF | splash10-03dl-9001000000-ec0113eb53d740f47bfc | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Fluticasone propionate 40V, Negative-QTOF | splash10-0ab9-9000000000-5ee0549770ddf526182a | 2021-09-25 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Specified | Not Specified | Taking drug identified by DrugBank entry DB00588 | | details | Urine | Expected but not Quantified | Not Quantified | Not Specified | Not Specified | Taking drug identified by DrugBank entry DB00588 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00588 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB023603 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 392059 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Fluticasone_Propionate |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 444036 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 31441 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Barkalow, Jufang; Chamberlin, Steven A.; Cooper, Arthur J.; Hossain, Azad; Hufnagel, John J.; Langrid Method for the preparation of fluticasone and related 17b-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods. 2001, Patent CA2400919A1 (https://patents.google.com/patent/CA2400919A1/en17) |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Dao Nguyen X, Robinson DS: Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol. 2004 Aug;114(2):296-301. [PubMed:15316506 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|